126 related articles for article (PubMed ID: 28753946)
21. A sensitive ELISA for the detection of bovine crude heparin in porcine heparin.
Levieux A; Rivera V; Levieux D
J Immunoassay Immunochem; 2001; 22(4):323-36. PubMed ID: 11816801
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of bioengineered heparin chemically and biologically similar to porcine-derived products and convertible to low MW heparin.
Douaisi M; Paskaleva EE; Fu L; Grover N; McManaman CL; Varghese S; Brodfuehrer PR; Gibson JM; de Joode I; Xia K; Brier MI; Simmons TJ; Datta P; Zhang F; Onishi A; Hirakane M; Mori D; Linhardt RJ; Dordick JS
Proc Natl Acad Sci U S A; 2024 Apr; 121(14):e2315586121. PubMed ID: 38498726
[TBL] [Abstract][Full Text] [Related]
23. Immunochemical control of the species origin of intestinal mucosa used for heparin purification.
Levieux D; Levieux A
J Immunoassay Immunochem; 2001; 22(2):127-45. PubMed ID: 11486811
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of an ion-exchange chromatography method for heparin and its impurities in heparin products.
Thiangthum S; Vander Heyden Y; Buchberger W; Viaene J; Prutthiwanasan B; Suntornsuk L
J Sep Sci; 2014 Nov; 37(22):3195-204. PubMed ID: 25146711
[TBL] [Abstract][Full Text] [Related]
25. [Collaborative study of Japanese Pharmacopoeia Heparin Sodium Reference Standard (Control 871)].
Yomota C; Hasegawa R; Komuro T; Okada S; Kimura T
Eisei Shikenjo Hokoku; 1989; (107):148-51. PubMed ID: 2636920
[TBL] [Abstract][Full Text] [Related]
26. Characterization of currently marketed heparin products: analysis of molecular weight and heparinase-I digest patterns.
Sommers CD; Ye H; Kolinski RE; Nasr M; Buhse LF; Al-Hakim A; Keire DA
Anal Bioanal Chem; 2011 Nov; 401(8):2445-54. PubMed ID: 21901459
[TBL] [Abstract][Full Text] [Related]
27. Characterization of currently marketed heparin products: key tests for quality assurance.
Keire DA; Ye H; Trehy ML; Ye W; Kolinski RE; Westenberger BJ; Buhse LF; Nasr M; Al-Hakim A
Anal Bioanal Chem; 2011 Jan; 399(2):581-91. PubMed ID: 20680615
[TBL] [Abstract][Full Text] [Related]
28. Establishment of replacement batches for heparin low-molecular-mass for calibration CRS, and the International Standard Low Molecular Weight Heparin for Calibration.
Mulloy B; Heath A; Behr-Gross ME
Pharmeuropa Bio; 2007 Dec; 2007(1):29-48. PubMed ID: 18413136
[TBL] [Abstract][Full Text] [Related]
29. Chromatographic molecular weight measurements for heparin, its fragments and fractions, and other glycosaminoglycans.
Mulloy B; Hogwood J
Methods Mol Biol; 2015; 1229():105-18. PubMed ID: 25325948
[TBL] [Abstract][Full Text] [Related]
30. Heparin sodium compliance to USP monograph: structural elucidation of an atypical 2.18 ppm NMR signal.
Mourier PA; Guichard OY; Herman F; Viskov C
J Pharm Biomed Anal; 2012; 67-68():169-74. PubMed ID: 22579602
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Low-Molecular-Weight Heparins Prepared From Bovine Heparins With Enoxaparin.
Liu X; St Ange K; Fareed J; Hoppensteadt D; Jeske W; Kouta A; Chi L; Jin C; Jin Y; Yao Y; Linhardt RJ
Clin Appl Thromb Hemost; 2017 Sep; 23(6):542-553. PubMed ID: 28056526
[TBL] [Abstract][Full Text] [Related]
32. Structural peculiarity and antithrombin binding region profile of mucosal bovine and porcine heparins.
Naggi A; Gardini C; Pedrinola G; Mauri L; Urso E; Alekseeva A; Casu B; Cassinelli G; Guerrini M; Iacomini M; Baigorria V; Torri G
J Pharm Biomed Anal; 2016 Jan; 118():52-63. PubMed ID: 26512999
[TBL] [Abstract][Full Text] [Related]
33. Comparison of bovine lung and porcine intestinal heparin for arterial thrombosis in man.
Bedford RF; O'Brien TE
Am J Hosp Pharm; 1977 Sep; 34(9):936-9. PubMed ID: 333906
[TBL] [Abstract][Full Text] [Related]
34. A quantitative PCR method to quantify ruminant DNA in porcine crude heparin.
Concannon SP; Wimberley PB; Workman WE
Anal Bioanal Chem; 2011 Jan; 399(2):757-62. PubMed ID: 21058016
[TBL] [Abstract][Full Text] [Related]
35. [Determination of anticoagulant activity of heparin].
Dalmora SL; Assaf GS; Dalmora ME; Vaucher LC; Vaccari SF
Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(2):59-62. PubMed ID: 1843369
[TBL] [Abstract][Full Text] [Related]
36. Determination of molecular weight of heparin by size exclusion chromatography with universal calibration.
Guo X; Condra M; Kimura K; Berth G; Dautzenberg H; Dubin PL
Anal Biochem; 2003 Jan; 312(1):33-9. PubMed ID: 12479832
[TBL] [Abstract][Full Text] [Related]
37. Analysis of oligosaccharides derived from heparin by ion-pair reversed-phase chromatography/mass spectrometry.
Doneanu CE; Chen W; Gebler JC
Anal Chem; 2009 May; 81(9):3485-99. PubMed ID: 19344114
[TBL] [Abstract][Full Text] [Related]
38. Enoxaparin for unstable angina and ancrod for cardiac surgery following heparin allergy.
Smith RE; Townsend GE; Berry BR; Bowen T
Ann Pharmacother; 1996 May; 30(5):476-80. PubMed ID: 8740327
[TBL] [Abstract][Full Text] [Related]
39. Determination of galactosamine impurities in heparin samples by multivariate regression analysis of their (1)H NMR spectra.
Zang Q; Keire DA; Wood RD; Buhse LF; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
Anal Bioanal Chem; 2011 Jan; 399(2):635-49. PubMed ID: 20953772
[TBL] [Abstract][Full Text] [Related]
40. Chromatographic Molecular Weight Measurements for Heparin , Its Fragments and Fractions, and Other Glycosaminoglycans.
Mulloy B; Hogwood J
Methods Mol Biol; 2022; 2303():227-240. PubMed ID: 34626382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
